Circulating tumour DNA in patients with advanced melanoma treated with dabrafenib or dabrafenib plus trametinib: a clinical validation study-Reference-Cited by-同舟云学术

Circulating tumour DNA in patients with advanced melanoma treated with dabrafenib or dabrafenib plus trametinib: a clinical validation study

Published:2021-03 Issue:3 Volume:22 Page:370-380
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Syeda Mahrukh M,Wiggins Jennifer M,Corless Broderick C,Long Georgina V,Flaherty Keith T,Schadendorf Dirk,Nathan Paul D,Robert Caroline,Ribas Antoni,Davies Michael A,Grob Jean Jacques,Gasal Eduard,Squires Matthew,Marker Mahtab,Garrett James,Brase Jan C,Polsky David

Funder

Novartis Pharmaceuticals Corporation

National Institutes of Health

Publisher

Elsevier BV

Subject

Oncology

Reference25 articles.

1. AJCC cancer staging manual,2017

2. Circulating tumor DNA analysis in the era of precision oncology;Said;Oncotarget,2020

3. Genomic classification of cutaneous melanoma;Cell,2015

4. Correlation of BRAF mutation status in circulating-free DNA and tumor and association with clinical outcome across four BRAFi and MEKi clinical trials;Santiago-Walker;Clin Cancer Res,2016

5. Association between circulating tumor DNA and pseudoprogression in patients with metastatic melanoma treated with anti-programmed cell death 1 antibodies;Lee;JAMA Oncol,2018

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating tumor tissue modified viral (TTMV)-HPV DNA in Recurrent, metastatic HPV-driven oropharyngeal cancer;Oral Oncology;2024-11

2. Detection of multiple activating NRAS variants under BRAF/MEK-inhibitor therapy in BRAF positive malignant melanoma using liquid biopsy;JAAD Case Reports;2024-10

3. Prognostic Role of Clinicopathological Characteristics and Serum Markers in Metastatic Melanoma Patients Treated with BRAF and MEK Inhibitors;Cancers;2024-08-27

4. DNA liquid biopsy-based prediction of cancer-associated venous thromboembolism;Nature Medicine;2024-08-15

5. Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments;Gut;2024-07-25